CLPT
Price
$12.16
Change
-$0.63 (-4.93%)
Updated
May 21 closing price
Capitalization
183.44M
82 days until earnings call
OPK
Price
$1.30
Change
-$0.03 (-2.26%)
Updated
May 21 closing price
Capitalization
920.03M
70 days until earnings call
Interact to see
Advertisement

CLPT vs OPK

Header iconCLPT vs OPK Comparison
Open Charts CLPT vs OPKBanner chart's image
ClearPoint Neuro
Price$12.16
Change-$0.63 (-4.93%)
Volume$224.85K
Capitalization183.44M
OPKO Health
Price$1.30
Change-$0.03 (-2.26%)
Volume$1.75M
Capitalization920.03M
CLPT vs OPK Comparison Chart
Loading...
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLPT vs. OPK commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPT is a StrongBuy and OPK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CLPT: $12.16 vs. OPK: $1.30)
Brand notoriety: CLPT and OPK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPT: 86% vs. OPK: 48%
Market capitalization -- CLPT: $183.44M vs. OPK: $920.03M
CLPT [@Medical Specialties] is valued at $183.44M. OPK’s [@Medical Specialties] market capitalization is $920.03M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPT’s FA Score shows that 0 FA rating(s) are green whileOPK’s FA Score has 0 green FA rating(s).

  • CLPT’s FA Score: 0 green, 5 red.
  • OPK’s FA Score: 0 green, 5 red.
According to our system of comparison, CLPT is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPT’s TA Score shows that 5 TA indicator(s) are bullish while OPK’s TA Score has 6 bullish TA indicator(s).

  • CLPT’s TA Score: 5 bullish, 5 bearish.
  • OPK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OPK is a better buy in the short-term than CLPT.

Price Growth

CLPT (@Medical Specialties) experienced а -2.17% price change this week, while OPK (@Medical Specialties) price change was +3.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.03%. For the same industry, the average monthly price growth was +8.10%, and the average quarterly price growth was -0.30%.

Reported Earning Dates

CLPT is expected to report earnings on Aug 12, 2025.

OPK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+1.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPK($920M) has a higher market cap than CLPT($183M). OPK YTD gains are higher at: -11.565 vs. CLPT (-20.936). CLPT has higher annual earnings (EBITDA): -20.99M vs. OPK (-65.52M). OPK has more cash in the bank: 95.9M vs. CLPT (23.1M). CLPT has less debt than OPK: CLPT (13.9M) vs OPK (327M). OPK has higher revenues than CLPT: OPK (863M) vs CLPT (24M).
CLPTOPKCLPT / OPK
Capitalization183M920M20%
EBITDA-20.99M-65.52M32%
Gain YTD-20.936-11.565181%
P/E RatioN/A26.11-
Revenue24M863M3%
Total Cash23.1M95.9M24%
Total Debt13.9M327M4%
FUNDAMENTALS RATINGS
CLPT vs OPK: Fundamental Ratings
CLPT
OPK
OUTLOOK RATING
1..100
706
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4463
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPT's Valuation (53) in the null industry is in the same range as OPK (68) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

CLPT's Profit vs Risk Rating (69) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

CLPT's SMR Rating (100) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

CLPT's Price Growth Rating (44) in the null industry is in the same range as OPK (63) in the Biotechnology industry. This means that CLPT’s stock grew similarly to OPK’s over the last 12 months.

OPK's P/E Growth Rating (98) in the Biotechnology industry is in the same range as CLPT (100) in the null industry. This means that OPK’s stock grew similarly to CLPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPTOPK
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 9 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CLPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEPX13.31N/A
N/A
Saratoga International Equity I
BPAIX31.73N/A
N/A
Boston Partners All Cap Value Instl
HQIRX20.75N/A
N/A
Hartford Equity Income R3
NCLEX29.19N/A
N/A
Nicholas Limited Edition I
GIDUX7.89N/A
N/A
Goldman Sachs Intl Eq Div & Prem R6

CLPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPT has been loosely correlated with ICUI. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPT jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPT
1D Price
Change %
CLPT100%
-4.93%
ICUI - CLPT
53%
Loosely correlated
-3.09%
ALGN - CLPT
44%
Loosely correlated
-5.84%
CERS - CLPT
42%
Loosely correlated
-6.72%
ILMN - CLPT
41%
Loosely correlated
-5.75%
NVST - CLPT
41%
Loosely correlated
-6.36%
More

OPK and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPK has been loosely correlated with ICUI. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OPK jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPK
1D Price
Change %
OPK100%
-2.26%
ICUI - OPK
36%
Loosely correlated
-3.09%
XAIR - OPK
35%
Loosely correlated
-4.52%
CRL - OPK
33%
Loosely correlated
-5.96%
HBIO - OPK
33%
Loosely correlated
-3.03%
CLPT - OPK
33%
Loosely correlated
-4.93%
More